Apotex a revu à la hausse le prix de son introduction en bourse à 24 $ par action
Outlets covering this story
Le Devoir
CENTER
Only one perspective covered this story — no diversity detected
Side-by-Side Outlet Comparison — Starter+
See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.
Unlock with Starter →